Pre-Interview with ANRF Scientists

Pre-Interview with ANRF Scientists

As part of the Arthritis National Research Foundation’s effort to educate and spread awareness on the various forms of Arthritis, we have created the interview series, Arthritis Now, in which different guests in the arthritis community will speak on recent news and developments.

Our next interviews will be with:

Dr. Timothy Niewold - Arthritis Now
Timothy Niewold, M.D.

Associate Professor
Mayo Clinic in Rochester, Minnesota
Dr. Niewold, Associate Professor of the Mayo Clinic in Rochester, Minnesota, who was funded by ANRF for research regarding lupus from 2009-2010.

Dr. Paul Utz - Arthritis Now
Paul Utz, M.D.

Professor of Medicine
Stanford University
Paul Utz, a researcher and rheumatologist who sees patients at Stanford University.

Dr. Nunzio Bottini - Arthritis Now
Nunzio Bottini, M.D.

Associate Professor
La Jolla Institute for Allergy & Immunology
And Dr. Nunzio Bottini, of the La Jolla Institute of Allergy and Immunology, researching autoimmune diseases.

If you’d like to hear your question asked to these esteemed investigators, leave your comments below. We’ll be selecting a few great questions to ask to each of these scientists during their interviews.

Stay tuned for more updates and to find out where you can see Arthritis Now!

Article Author
Arthritis National Research Foundation

The Arthritis National Research Foundation's mission is to provide initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases. Writing articles about the patients affected and the science being done to find a cure shows why we need to come together to #CureArthritis!

  • Avatar
    Kathy Mallon
    Posted at 20:57h, 18 September Reply

    What do “we” now know about the link between Non-Hodgkins Lymphoma and some of the biological medicines? My Mom and her Uncle both died of N-HL and I have a son and daughter with very active systemic JIA. I had it as a child and it has returned. I can’t help but feel that there is a genetic issue that sometimes causes the N-HL to come about on the medicine. Do you have a test to see if it is safe for us to use the biologicals? In the same line: when looking into the rare times when biologicals have caused the N-HL, do we know if all of them took MTX and/or Cyclosporin prior to the biological meds? Or, if some/none did? I don’t have access to these studies. Thank you.

  • Avatar
    Posted at 21:45h, 18 September Reply

    Can you please give an overview on the significance of HLA B27 in diagnosing Ankylosing spondylitis both on a Juvenile and Adult level? My daughter has Polyarticular JIA. She began to have back pain and was tested for HLA B27 and came back positive. I have had significant back issues as well as sacrioiliac joint problems for years. I remain undiagnosed. I too came back positive for HLA B27. She is 7 years old and I am 36.

    This seems to be a complex issue, diagnosing AS.

    Thank You!

  • Avatar
    Shirley Gutkowski, RDH, BSDH
    Posted at 12:37h, 19 September Reply

    How can rheumatologists work with dental hygienists to reduce the overall inflammatory load on patients with RA. We know that all inflammatory markers are decreased once the mouth is cleaned up. Maintaining that is nearly impossible without professional intervention. Referring to a dentist is a crap shoot, as no dentist cleans teeth and you have to trust that the dentist has hired a dental hygienist who is engaged in the whole body treatment idea of the practice of dental hygiene.
    Don’t forget that in moderate disease those who have periodontal disease and 20 teeth have an open infected wound the size of your palm. Any other infected wound that size would be an emergency.

  • Avatar
    Patricia L Boerner, President, International Still's Disease Foundation, Inc.
    Posted at 03:57h, 01 October Reply

    I am president and assist in moderating several of the International Still’s Disease Foundation’s online support groups for those that have any related interest in SOJIA (Still’s) and Adult Onset Still’s disease.
    A topic has recently come up that we cannot find information about online. One member is a young adult female Still’s patient being treated with disease modifying anti-rheumatic drugs on and off for some years and wants to know if these medications, along with the immunosuppressant properties places her at a higher risk for developing cervical cancer as is possible with getting other types of cancer and these drugs? she has also asked if a woman’s test results (Pap – colposcopy) has shown an advancement from CIN 2 to CIN 3 would it be advised to continue DMARD treatment? If not, at what stage would it be recommended to discontinue these medications and at what point safe to resume? And, can the DMARD’s being prescribed over a period of years cause one test to be positive for CIN2, another after to be normal and then have advanced to CIN3 while still using DMARD therapy?
    Thank you for any knowledge and advice you can share on this topic.

Post A Comment